SMS Pharmaceuticals: The financial results for the period ended September 30, 2026
SMS Pharmaceuticals (SMSPHARMA) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹4,869 crore.
What happened
SMS Pharmaceuticals (SMSPHARMA) filed a disclosure with the exchanges on 4 November 2026 at 01:26 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
SMS Pharmaceuticals is a small-cap company, with a market value of about ₹4,869 crore.
The stock last traded at ₹520, against a 52-week range of ₹270.1–₹535 (2.8% below the high).
Before this filing the shares had moved +9.1% over the month and +41.4% over three months. Average daily turnover over the last 20 sessions was about ₹29.59 crore.
Promoters held 68.07% at the end of Q1 FY27; 17.99% of promoter shares were pledged. Foreign institutions owned 0.65% and domestic institutions 2.83%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 196 | 20.5 | 2.31 |
| Q2 FY26 | 242 | 25.3 | 2.84 |
| Q3 FY26 | 210 | 23.5 | 2.59 |
| Q4 FY26 | 238 | 33 | 3.58 |
| Q1 FY27 | 207 | 20.9 | 2.23 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 4 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- SMS Pharmaceuticals Limited Estimates – NSE:SMSPHARMA
- SMS Pharmaceuticals gets appellate order vacating ₹45.63 crore tax demand
- SMS Pharmaceuticals (SMSPHARMA) Share Price Rises 8.06% to Rs 477.95 Today
- SMS Pharmaceuticals loses income tax appeal on AY 2018-19 demand
- Broad-Based Technical Strength Lifts SMS Pharmaceuticals Ltd to 52-Week High of Rs 524.95
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.